- Home
- MNOV vs RDZN Comparison
MNOV vs RDZN Comparison
Compare MNOV & RDZN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MNOV
- RDZN
- Stock Information
- Founded
- MNOV 2000
- RDZN 2015
- Country
- MNOV United States
- RDZN United States
- Employees
- MNOV N/A
- RDZN N/A
- Industry
- MNOV Biotechnology: Pharmaceutical Preparations
- RDZN Blank Checks
- Sector
- MNOV Health Care
- RDZN Finance
- Exchange
- MNOV Nasdaq
- RDZN Nasdaq
- Market Cap
- MNOV 68.2M
- RDZN 79.4M
- IPO Year
- MNOV 2005
- RDZN N/A
- Fundamental
- Price
- MNOV $1.25
- RDZN $1.05
- Analyst Decision
- MNOV Strong Buy
- RDZN Strong Buy
- Analyst Count
- MNOV 2
- RDZN 2
- Target Price
- MNOV $7.00
- RDZN $5.00
- AVG Volume (30 Days)
- MNOV 14.8K
- RDZN 688.0K
- Earning Date
- MNOV 08-07-2025
- RDZN 08-12-2025
- Dividend Yield
- MNOV N/A
- RDZN N/A
- EPS Growth
- MNOV N/A
- RDZN N/A
- EPS
- MNOV N/A
- RDZN N/A
- Revenue
- MNOV N/A
- RDZN $44,296,098.00
- Revenue This Year
- MNOV N/A
- RDZN $69.48
- Revenue Next Year
- MNOV N/A
- RDZN $35.89
- P/E Ratio
- MNOV N/A
- RDZN N/A
- Revenue Growth
- MNOV N/A
- RDZN N/A
- 52 Week Low
- MNOV $1.12
- RDZN $0.68
- 52 Week High
- MNOV $2.55
- RDZN $3.10
- Technical
- Relative Strength Index (RSI)
- MNOV 36.85
- RDZN 52.18
- Support Level
- MNOV $1.32
- RDZN $0.95
- Resistance Level
- MNOV $1.38
- RDZN $1.22
- Average True Range (ATR)
- MNOV 0.05
- RDZN 0.12
- MACD
- MNOV -0.00
- RDZN -0.00
- Stochastic Oscillator
- MNOV 0.00
- RDZN 48.48
About MNOV Medicinova Inc
MediciNova Inc is a biopharmaceutical company. The company acquires and develops small-molecule therapeutics for the treatment of diseases with unmet medical needs with a specific focus on the U.S. market. Its products portfolio includes therapeutics such as MN-001, MN-166, MN-221 etc. The firm's current strategy is to focus its development activities on therapeutics for neurological disorders and fibrotic diseases.
About RDZN Roadzen Inc.
Roadzen Inc is an insurance technology company on a mission to transform global auto insurance powered by advanced AI. Its clients comprise major insurers, fleets, and carmakers to small fleets, brokers, and insurance agents that use Roadzen's technology to build new products, sell insurance, process claims, and improve road safety. The company's work in telematics and computer vision has earned recognition as an AI innovator by publications such as Forbes, Fortune, and Financial Express.